Cipaglucosidase alfa (Pombiliti)

Enzyme replacement therapy (lysosomal enzyme)

Cipaglucosidase alfa (Pombiliti)

Forms and strengths
Form: TabletStrength: 105 mg/vial (reconstituted to 15 mg/mL)
Print

Indication

  • Cipaglucosidase alfa, given together with miglustat capsules, is indicated for the treatment of late-onset Pompe disease (acid alpha-glucosidase deficiency) in adults weighing at least 40 kg.
  • It is not authorized for use as a stand-alone therapy; it must always be paired with miglustat capsules.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.